---
figid: PMC7526126__40364_2020_228_Fig3_HTML
figlink: pmc/articles/PMC7526126/figure/Fig3/
number: F3
caption: Mechanisms of interferon-γ mediated cancer regression. The IFN-γ stimulates
  activation of JAK/STAT signaling in the TME what further drives increased caspase
  activity and downregulation of SLC7A11 and SLC3A2. Consequently, cancer cells undergone
  apoptosis directly or through induced lipid peroxidation and ferroptosis. IFN-γ
  induces fragility of Tregs and inhibits the formation of tumor blood vessels by
  downregulating VEGF-A. Additionally, tumor angiogenesis is inhibited by IFN-γ-induced
  endothelial cells destruction. Through stimulation of M1 macrophage polarization
  and inhibition of their M2 phenotype, it contributes to effective antitumor immune
  response. The IFN-γ can stimulate p16INK4a-Rb pathway and thus, tumor senescence,
  while IFN-γ-mediated activation of IDO1-Kyn-AhR-p27 pathway shifts tumors to a dormant
  state. Moreover, IFN-γ increases FN1 expression that limits cancer metastasis. SLC7A11-solute
  carrier family 7 member 11; SLC3A2-solute carrier family 3 member 2); IDO1-indoleamine
  2,3-dioxygenase 1; Kyn-kynurenine; AhR-aryl hydrocarbon receptor; p27-cyclin-dependent
  kinase inhibitor 1B; p16INK4a-p16(INK4a) cyclin-dependent kinase; Rb-retinoblastoma;
  FN1-fibronectin-1
pmcid: PMC7526126
papertitle: 'Roles of IFN-γ in tumor progression and regression: a review.'
reftext: Dragica Jorgovanovic, et al. Biomark Res. 2020;8:49.
pmc_ranked_result_index: '12095'
pathway_score: 0.9497061
filename: 40364_2020_228_Fig3_HTML.jpg
figtitle: InterferonG mediated cancer regression
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7526126__40364_2020_228_Fig3_HTML.html
  '@type': Dataset
  description: Mechanisms of interferon-γ mediated cancer regression. The IFN-γ stimulates
    activation of JAK/STAT signaling in the TME what further drives increased caspase
    activity and downregulation of SLC7A11 and SLC3A2. Consequently, cancer cells
    undergone apoptosis directly or through induced lipid peroxidation and ferroptosis.
    IFN-γ induces fragility of Tregs and inhibits the formation of tumor blood vessels
    by downregulating VEGF-A. Additionally, tumor angiogenesis is inhibited by IFN-γ-induced
    endothelial cells destruction. Through stimulation of M1 macrophage polarization
    and inhibition of their M2 phenotype, it contributes to effective antitumor immune
    response. The IFN-γ can stimulate p16INK4a-Rb pathway and thus, tumor senescence,
    while IFN-γ-mediated activation of IDO1-Kyn-AhR-p27 pathway shifts tumors to a
    dormant state. Moreover, IFN-γ increases FN1 expression that limits cancer metastasis.
    SLC7A11-solute carrier family 7 member 11; SLC3A2-solute carrier family 3 member
    2); IDO1-indoleamine 2,3-dioxygenase 1; Kyn-kynurenine; AhR-aryl hydrocarbon receptor;
    p27-cyclin-dependent kinase inhibitor 1B; p16INK4a-p16(INK4a) cyclin-dependent
    kinase; Rb-retinoblastoma; FN1-fibronectin-1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EN1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - CASP3
  - CASP9
  - CASP8
  - CASP7
  - SLC7A11
  - SLC3A2
  - HIF1A
  - VEGFA
  - SREBF1
genes:
- word: ↑EN1
  symbol: EN1
  source: hgnc_symbol
  hgnc_symbol: EN1
  entrez: '2019'
- word: EN1
  symbol: EN1
  source: hgnc_symbol
  hgnc_symbol: EN1
  entrez: '2019'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: ↑JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ↑JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: ↑JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: ↑JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: ↑JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ↑Casp3,7,8,9
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Casp3,7,8,9
  symbol: CASP9
  source: hgnc_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Casp3,7,8,9
  symbol: CASP8
  source: hgnc_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Casp3,7,8,9
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Casp3,7,8,9
  symbol: CASP7
  source: hgnc_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: SLC7A11
  symbol: SLC7A11
  source: hgnc_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: SLC3A2
  symbol: SLC3A2
  source: hgnc_symbol
  hgnc_symbol: SLC3A2
  entrez: '6520'
- word: HIF1A
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: SREBP1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
chemicals: []
diseases: []
figid_alias: PMC7526126__F3
redirect_from: /figures/PMC7526126__F3
figtype: Figure
---
